🇺🇸 FDA
Patent

US 8663622

Recombinant vaccine viruses expressing IL-15 and methods using the same

granted A61KA61K2039/5256A61K2039/545

Quick answer

US patent 8663622 (Recombinant vaccine viruses expressing IL-15 and methods using the same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/5256, A61K2039/545, A61K2039/55527, A61K2039/57